Clinical trial

Phase II Study of ASP3550 in Patients With Prostate Cancer

NCT00568516

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-10-01

PhasePHASE2

Study timeline

Study start (unknown)2007-10-01Date precision: month

Registry last updated2014-10-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostatic Neoplasmsunresolved

Interventions

ASP3550DRUG

Sponsors & collaborators

Astellas Pharma Inclead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00568516 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.